Tresiba Injection Penfill, from Novo Nordisk Pharma, contains insulin degludec (recombinant), an ultra-long-acting insulin used for managing blood sugar levels in patients with type 1 and type 2 diabetes mellitus. This injectable drug, YJ code 2492419A1029, is supplied as 300 units per tube.
Tresiba Injection Penfill
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →